Telaprevir's Chemistry Speeds HCV Treatment Time

[Guest guest]

Telaprevir's Chemistry Speeds HCV Treatment Time

Upon further study of telaprevir, researchers have determined that it may dramatically shorten the time required for successful Hepatitis C therapy.

Telaprevir Increases Second-Phase Hepatitis C Decline

Analysis of the kinetics of telaprevir treatment for hepatitis C virus shows a rapid second-phase viral decline, which may allow for shorter duration of treatment, according to a study published online March 7 in Hepatology.

FRIDAY, April 8 (HealthDay News) -- Analysis of the kinetics of telaprevir treatment for hepatitis C virus (HCV) shows a rapid second-phase viral decline, which may allow for shorter duration of treatment, according to a study published online March 7 in Hepatology.

Jeremie Guedj, Ph.D., and Alan S. Perelson, Ph.D., from the Los Alamos National Laboratory in New Mexico, examined second-phase HCV viral decline during treatment with telaprevir. Two aspects of telaprevir treatment were investigated: the effect of varying regimens of telaprevir monotherapy in 28 participants, and the comparison of telaprevir monotherapy in eight patients with telaprevir plus interferon therapy in eight patients. Using a new viral kinetic model, and assuming that drug resistance can be avoided, the treatment time needed to eliminate all virus and infected cells was estimated.

Continue reading this entire article:http://www.doctorslounge.com/index.php/news/pb/19244

http://www.hepatitis-central.com/mt/archives/2011/04/telaprevirs_che.html